NO20053133L - Kjemiske forbindelser. - Google Patents

Kjemiske forbindelser.

Info

Publication number
NO20053133L
NO20053133L NO20053133A NO20053133A NO20053133L NO 20053133 L NO20053133 L NO 20053133L NO 20053133 A NO20053133 A NO 20053133A NO 20053133 A NO20053133 A NO 20053133A NO 20053133 L NO20053133 L NO 20053133L
Authority
NO
Norway
Prior art keywords
formula
optionally substituted
independently selected
chemical connections
tebazolyl
Prior art date
Application number
NO20053133A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053133D0 (no
Inventor
Michael Barry Gravestock
Folkert Reck
Fei Zhou
Nail James Hales
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0227704A external-priority patent/GB0227704D0/en
Priority claimed from GB0310828A external-priority patent/GB0310828D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20053133D0 publication Critical patent/NO20053133D0/no
Publication of NO20053133L publication Critical patent/NO20053133L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20053133A 2002-11-28 2005-06-27 Kjemiske forbindelser. NO20053133L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0227704A GB0227704D0 (en) 2002-11-28 2002-11-28 Chemical compounds
GB0310828A GB0310828D0 (en) 2003-05-10 2003-05-10 Chemical compounds
PCT/GB2003/005091 WO2004048350A2 (en) 2002-11-28 2003-11-24 Oxazolidinones as antibacterial agents

Publications (2)

Publication Number Publication Date
NO20053133D0 NO20053133D0 (no) 2005-06-27
NO20053133L true NO20053133L (no) 2005-07-15

Family

ID=32395888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053133A NO20053133L (no) 2002-11-28 2005-06-27 Kjemiske forbindelser.

Country Status (12)

Country Link
US (1) US7498350B2 (ko)
EP (1) EP1581524A2 (ko)
JP (1) JP2006515601A (ko)
KR (1) KR20050084010A (ko)
AU (1) AU2003285509A1 (ko)
BR (1) BR0316690A (ko)
CA (1) CA2507628A1 (ko)
MX (1) MXPA05005522A (ko)
NO (1) NO20053133L (ko)
SA (1) SA04250095A (ko)
TW (1) TW200533667A (ko)
WO (1) WO2004048350A2 (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2477344A1 (en) 2002-02-28 2003-09-04 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
US7199143B2 (en) 2002-02-28 2007-04-03 Astrazeneca Ab Chemical compounds
RU2348628C2 (ru) 2003-07-02 2009-03-10 Мерк Энд Ко., Инк. Замещенные циклопропильной группой оксазолидиноновые антибиотики и их производные
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
AU2005247670A1 (en) * 2004-05-25 2005-12-08 Astrazeneca Ab 3- {4- (pyridin-3-yl) phenyl} -5- (1H-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
EP1912980A2 (en) * 2005-06-20 2008-04-23 Wockhardt Limited Oxazolidinones bearing antimicrobial activity composition and methods of preparation
US8288416B2 (en) 2006-09-25 2012-10-16 Wockhardt Ltd. Substituted piperidinophenyl oxazolidinones
WO2008069619A1 (en) * 2006-12-08 2008-06-12 Legochem Bioscience Ltd. Novel oxazolidinone derivatives, process for preparing thereof and pharmaceutical composition containing the same
JP5236246B2 (ja) * 2007-10-18 2013-07-17 株式会社クラレ スルホニルハライド誘導体の製造方法
JP5352387B2 (ja) * 2008-09-02 2013-11-27 株式会社クラレ スルトン誘導体の製造方法
ES2744907T3 (es) 2008-10-10 2020-02-26 Merck Sharp & Dohme Compuestos usados en la síntesis de oxazolidinonas
MX2011008093A (es) 2009-02-03 2011-11-29 Trius Therapeutics Forma cristalina del fosfato de dihidrogeno r)-3-(4-(2-(2-metiltet razol-5-il)piridin-5-il)-3-fluorofenil)-5-hidroximetil oxazolidin-2-ona.
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR101128029B1 (ko) 2010-03-08 2012-03-29 주식회사 레고켐 바이오사이언스 (ｒ)-3-(3-플루오로-4-(1-메틸-5,6-다이하이드로-1,2,4-트리아진-4(1ｈ)-일)페닐)-5-(치환된 메틸)옥사졸리딘-2-온 유도체의 제조방법
FR2975990B1 (fr) * 2011-06-01 2013-05-24 Rhodia Operations Procede de preparation d'un compose organique fluore
TW201609651A (zh) 2013-11-12 2016-03-16 陶氏農業科學公司 用於氟化化合物之過程（一）
BR102014028164A2 (pt) * 2013-11-12 2015-09-08 Dow Agrosciences Llc processo para fluoração de compostos
TW201609652A (zh) 2013-11-12 2016-03-16 陶氏農業科學公司 用於氟化化合物之過程（三）
KR101561964B1 (ko) 2013-11-15 2015-10-20 한국과학기술연구원 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물
WO2016061772A1 (en) 2014-10-22 2016-04-28 Merck Sharp & Dohme Corp. Nargenicin compounds and uses thereof as antibacterial agents
TWI726900B (zh) 2015-08-04 2021-05-11 美商陶氏農業科學公司 用於氟化化合物之過程
KR101855334B1 (ko) * 2015-12-11 2018-06-08 에스티팜 주식회사 옥사졸리디논 유도체의 중간체 제조방법
EP3723758A4 (en) 2017-12-13 2021-06-23 Merck Sharp & Dohme Corp. PHARMACEUTICAL COMPOSITIONS OF TEDIZOLID PHOSPHATE
CA3092680A1 (en) 2018-03-07 2019-09-12 Cyclerion Therapeutics, Inc. Process for preparing soluble guanylate cyclase stimulators
IL299155A (en) 2020-06-18 2023-02-01 Akagera Medicines Inc Oxazolidinone compounds, liposome preparations containing oxazolidinone compounds and methods of using them

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
MXPA02012045A (es) * 2000-06-05 2003-10-15 Dong A Pharm Co Ltd Nuevos derivados de oxazolidinona y proceso para su preparacion.
US20020115669A1 (en) * 2000-08-31 2002-08-22 Wiedeman Paul E. Oxazolidinone chemotherapeutic agents
DE60212959T2 (de) * 2001-04-07 2007-02-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
ES2244802T3 (es) * 2001-09-11 2005-12-16 Astrazeneca Ab Derivados de oxazolidinona y/o isoxazolina como agentes antibacterianos.
JP2005519870A (ja) * 2001-10-25 2005-07-07 アストラゼネカ アクチボラグ 抗菌活性をもつアリール置換オキサゾリジノン類
US7199143B2 (en) * 2002-02-28 2007-04-03 Astrazeneca Ab Chemical compounds
CA2477344A1 (en) * 2002-02-28 2003-09-04 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
GB0227701D0 (en) 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds
BR0316688A (pt) 2002-11-28 2005-10-18 Astrazeneca Ab Composto, prodroga de um composto, método de produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto

Also Published As

Publication number Publication date
EP1581524A2 (en) 2005-10-05
NO20053133D0 (no) 2005-06-27
BR0316690A (pt) 2005-10-18
US7498350B2 (en) 2009-03-03
JP2006515601A (ja) 2006-06-01
WO2004048350A3 (en) 2004-10-21
SA04250095A (ar) 2005-12-03
US20060116386A1 (en) 2006-06-01
MXPA05005522A (es) 2005-07-25
TW200533667A (en) 2005-10-16
CA2507628A1 (en) 2004-06-10
WO2004048350A2 (en) 2004-06-10
KR20050084010A (ko) 2005-08-26
AU2003285509A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
NO20053133L (no) Kjemiske forbindelser.
NO20062269L (no) Pyridin-karboksylsyrederivater som glucokinasemodulatorer
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
NO20063446L (no) Tiazolderivater
NO20073926L (no) Pyrazolforbindelser som modulerer aktivitet av CDK-, GSK- og aurorakinaser
NO20073960L (no) Pyrazolderivater for inhibering av CDK og GSK
ATE241617T1 (de) Pyrimidinverbindungen
NO20052534L (no) Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer
DE60128343D1 (de) Pyrimidine verbindungen
NO20051165L (no) Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
NO20052038L (no) Ny adeninforbindelse og anvendelse derav
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
TW200640900A (en) 1-(2h)-isoquinolone derivative
NO20085169L (no) Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes
ATE377420T1 (de) Phenylalkansäure- und phenyloxyalkansäure- derivate als hppar aktivatore
CY1106358T1 (el) Νεοι δικυκλικοι αναστολεις της ορμονοευαισθητης λιπασης
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
MY139887A (en) Tetrahydronaphthyridine derivatives and a process for preparing the same.
ATE386012T1 (de) Phenyloxyalkansäure-derivate als hppar aktivatore
NO20070157L (no) Substituerte diketopiperaziner som oksytocinantagonister
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
NO20043951L (no) 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
TW200510361A (en) Process of preparating 3-acylaminobenzofuran-2-carboxylic acid derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application